Approval · Notice of Compliance 2987 · 1998

AVAPRO: Notice of Compliance 2987

Issued June 1, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 2987
Date: June 1, 1998
Company: Sanofi Winthrop Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: New Active Substance (NAS)
Therapeutic class: Angiotensin ii receptor antagonist

Products in this notice

Brand	DIN	Status today
AVAPRO	02237923	Cancelled Post Market
AVAPRO	02237924	Marketed
AVAPRO	02237925	Marketed

Medicinal ingredients

IRBESARTAN 75 MG per TAB
IRBESARTAN 150 MG per TAB
IRBESARTAN 300 MG per TAB